Dr. Adrienne Duff:

As part of our review and engagement with the scoping inquiry, and based on a full technical review of the evidence we gathered over our annual assessments to MedLab and the fact it was operating a common system of management across its sites, we reviewed the competence and quality assurance of the cytoscreeners involved in the testing. We reviewed the application of its common management system, control of the laboratories and the staff involved. The cytoscreening activities performed at the Manchester site have been accredited since they started.